Incyte Corp. (INCY)
100.05
-8.98
(-8.24%)
USD |
NASDAQ |
Feb 10, 16:00
99.34
-0.71
(-0.71%)
After-Hours: 20:00
Incyte EPS Diluted (Quarterly) : 1.46 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Centene Corp. | -2.240 |
| Pfizer Inc. | -0.2898 |
| Bio-Techne Corp. | 0.2421 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 299.28M |
| Revenue (Quarterly) | 1.507B |
| Total Expenses (Quarterly) | 1.208B |
| Enterprise Value | 16.10B |
| Gross Profit Margin (Quarterly) | 92.32% |
| Profit Margin (Quarterly) | 19.86% |
| Earnings Yield | 6.40% |
| Operating Earnings Yield | 6.68% |